article thumbnail

ID: 4121762 Transforming Cardio-Oncology Care with Wearable Technology – Using Smartwatches to Monitor for Arrhythmias in Vulnerable Patient Populations

HeartRhythm

The role of wearable technology in detecting AF in cardio-oncology has not been well defined. Patients with CLL are at increased risk of developing atrial fibrillation (AF), however AF is a known side effect of ibrutinib therapy as well and is associated with worse outcomes.

article thumbnail

How to Use Imaging: Complex Cases of Atherosclerosis, Myocardial Inflammation, and Cardiomyopathy in Cardio-Oncology

Circulation: Cardiovascular Imaging

As the field of cardio-oncology continues to expand rapidly, guidance on the management of such toxicities and the development of imaging technologies is crucial. These methods have unique considerations and in recent years have made significant progress in their diagnostic capabilities in this patient population.

article thumbnail

Results Involving Philips FDA-cleared AI-enabled Cardiovascular Ultrasound Platform to be Presented at American Society of Echocardiography Scientific Sessions, ASE 2024

DAIC

Image courtesy: Philips christine.book Wed, 06/12/2024 - 14:07 June 12, 2024 — Royal Philips has announced its next-generation AI-enabled cardiovascular ultrasound platform to help speed up cardiac ultrasound analysis with proven AI technology and reduce the burden on echocardiography labs.